updated 1/5/2011 5:17:08 PM ET 2011-01-05T22:17:08

MOUNTAIN VIEW, Calif., Jan. 5, 2011 (GLOBE NEWSWIRE) -- Complete Genomics (Nasdaq:GNOM) announced today that the Company will present at the upcoming J.P. Morgan Healthcare Conference in San Francisco on January 13, 2011. The presentation is scheduled to begin at 11:30 a.m. Pacific Standard Time and will a feature an overview of the company by Dr. Clifford A. Reid, Chairman, President, and Chief Executive Officer.

The presentation will be accessible via a webcast through a link posted on the Investor Events and Presentations section of the Complete Genomics website: http://ir.completegenomics.com . The webcast will be available for replay until February 28, 2011.

About Complete Genomics

Complete Genomics is a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA™ Platform) combines Complete Genomics' proprietary human genome sequencing technology with our advanced informatics and data management software. We offer this innovative, end-to-end, outsourced solution as CGA™ Service, and provide customers with data that is immediately ready to be used for genome-based research.

The Complete Genomics logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8216

CONTACT:  Complete Genomics, Inc.
          Investor Relations
          Scott Sandler
          (650) 943-2788
          ssandler@completegenomics.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 1.97%
$30K home equity loan FICO 5.80%
$75K home equity loan FICO 4.54%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.70%
13.70%
Cash Back Cards 17.91%
17.91%
Rewards Cards 17.17%
17.17%
Source: Bankrate.com